SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Xiuning Le

Xiuning Le

Associate Professor, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston

Dr Xiuning Le is an associate professor in the Department of Thoracic/Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center in Houston, USA. Her clinical and translational work focuses on oncogene-driven non-small cell lung cancer, including EGFR-mutant and MET exon 14 skipping disease, HER2 mutations, and mechanisms of resistance to targeted therapy. She has contributed to practice-shaping trials, including as first author of the RAMOSE study of osimertinib with or without ramucirumab in EGFR-mutant NSCLC, and has reported on emerging HER2-targeted therapy in lung cancer. She is a member of ESMO, the IASLC, ASCO, and the AACR, and is a frequent speaker at major international oncology congresses.

Connect

Xiuning Le

Featured in

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates